ArticleMolecular cancer research : MCR2022

Diurnal Expression of PD-1 on Tumor-Associated Macrophages Underlies the Dosing Time-Dependent Antitumor Effects of the PD-1/PD-L1 Inhibitor BMS-1 in B16/BL6 Melanoma-Bearing Mice.

Akito Tsuruta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.